Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Development of antagonists that disrupt the hyperactivated camp signalling pathway in immunodeficiencies as immunostimulatory therapy (NEW CAMP ANTAGONISTS)

Dal 2002-12-01 al 2005-01-31

Dettagli del progetto

Costo totale:

EUR 1 901 224

Contributo UE:

EUR 945 844

Coordinato in:

Norway

Meccanismo di finanziamento:

CRS - Cooperative research contracts

Coordinatore

LAURAS AS
Norway
Gaustadalleen 21
0349 OSLO
Norway
See on map
Contatto amministrativo: Wenche Marie OLSEN

Partecipanti

BIAFFIN GMBH & CO KG
Germany
Universitaetstrasse 150
44870 BOCHUM
Germany
See on map
Contatto amministrativo: Bastian ZIMMERMANN
BIOLOG LIFE SCIENCE INSTITUTE, FORSCHUNGSLABOR UND BIOCHEMICA- VERTRIEB GMBH
Germany
Flughafendamm 9a
28199 BREMEN
Germany
See on map
Contatto amministrativo: Hans-Gottfried GENIESER
UNIVERSITE DE LIEGE
Belgium
Avenue de l'Hopital, 13 bat. B 35
4000 LIEGE
Belgium
See on map
Contatto amministrativo: Willy LEGROS
UNIVERSITY OF KASSEL
Germany
Heinrich Piett Strasse, 40, Raum 2161
34132 KASSEL
Germany
Contatto amministrativo: Manfred NETTEKOVEN
Fax: +38-61-2804484
UNIVERSITY OF OSLO
Norway
Sognvannsveien 9
0317 OSLO
Norway
See on map
Contatto amministrativo: Toril JOHANSSON